Home | Articles
Published on:12-2014
Indian Journal of Pharmaceutical Education and Research, 2014; 48(Suppl):139-148
Pharmaceutical Research | doi:10.5530/ijper.48.4s.17

Antipsoriatic and Inhibitory effects of an oral dosage form containing Bioflavonoids on inflammatory cytokines IL-1α, IL-1β, IL-6, IL-8, IL-17 and TNF-α


Authors and affiliation (s):

A Vijayalakshmia*, V Ravichandirana and K Masilamanib

aDepartment of Pharmacognosy, School of Pharmaceutical Sciences, VISTAS, Vels University, Pallavaram, Chennai-117, Tamilnadu, India

bDepartment of Pharmaceutical Engineering, University Malaysia Pahang, Lebuhraya Tun Razak 26300 Gambang, Kuantan Pahang Darul Makmur

Abstract:

Objective: The present study aimed to develop and evaluate orally administrable dosage form containing bioactive flavonoids viz., Luteolin-7-O-β-D-Glucuronide (II), Kaempferol 3-O-[2-O-(6-O-feruloyl)-β-D-glucopyranosyl]-β- D-galactopyranoside (III) from the bark of Givotia rottleriformis and Formononetin-7-O-β-D-glucoside (VI) from the leaves of Cassia tora. Methods: The formulation was developed and evaluated as per official compendia. The developed formulation was evaluated for antipsoriatic activity using rat UV ray photo dermatitis model and cytokine inhibition assay. Results: Evaluation parameters observed optimum range of formulations and the tablets were suitable for oral administration. The formulation exhibited antipsoriatic activity by good reduction in the thickness of epidermis, significant retention of the stratum granulosum and the absence of movement of neutrophils in UV-B induced psoriasis. In cytokine inhibition assay, the formulation showed remarkable inhibition of IL-17 and TNF- α, key cytokines involved in the pathogenesis of psoriasis at higher concentration. Conclusion: The study can be concluded that the developed formulation can be effective and safety as dietary supplements with health benefits to psoriatic patients.

Key words: Givotia rottleriformis, Cassia tora, Psoriasis, Formulation, Cytokines.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics, 2023): 0.8

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs